Skip to main content
TipRanks
Go Ultimate75% OFF

CSPC Pharmaceutical Group (1093) Financial Statements

35 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently HK$92.15B. The company's EPS TTM is HK$0.65; its P/E ratio is 10.50; and it has a dividend yield of 4.11%. CSPC Pharmaceutical Group is estimated to report earnings on November 18, 2026, and the estimated EPS forecast is HK$0.09. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueHK$ 25.33BHK$ 29.54BHK$ 31.47BHK$ 31.59BHK$ 27.41B
Gross ProfitHK$ 16.62BHK$ 20.67BHK$ 22.19BHK$ 22.73BHK$ 20.79B
Operating IncomeHK$ 3.87BHK$ 5.45BHK$ 7.01BHK$ 6.93BHK$ 6.14B
EBITDAHK$ 5.24BHK$ 7.16BHK$ 8.59BHK$ 8.83BHK$ 7.58B
Net IncomeHK$ 3.78BHK$ 4.41BHK$ 5.88BHK$ 6.22BHK$ 5.51B
Balance Sheet
Cash & Short-Term InvestmentsHK$ 8.87BHK$ 7.75BHK$ 13.09BHK$ 13.87BHK$ 10.73B
Total AssetsHK$ 46.72BHK$ 44.36BHK$ 46.28BHK$ 41.18BHK$ 34.68B
Total DebtHK$ 641.38MHK$ 507.33MHK$ 706.90MHK$ 582.54MHK$ 93.87M
Net DebtHK$ -5.45BHK$ -5.86BHK$ -11.31BHK$ -9.72BHK$ -9.17B
Total LiabilitiesHK$ 12.15BHK$ 10.52BHK$ 11.26BHK$ 10.06BHK$ 7.91B
Stockholders' EquityHK$ 33.19BHK$ 32.24BHK$ 33.20BHK$ 29.77BHK$ 25.94B
Cash Flow
Free Cash FlowHK$ 3.99BHK$ 1.74BHK$ 2.29BHK$ 6.62BHK$ 2.88B
Operating Cash FlowHK$ 5.90BHK$ 4.53BHK$ 4.18BHK$ 8.10BHK$ 4.64B
Investing Cash FlowHK$ -4.13BHK$ -4.41BHK$ 607.27MHK$ -7.19BHK$ -637.33M
Financing Cash FlowHK$ -2.44BHK$ -5.11BHK$ -2.30BHK$ -1.95BHK$ -2.20B

Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

012B24B36B12 %15 %18 %21 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

CSPC Pharmaceutical Group Liabilities to Assets

020B40B60B20 %25 %30 %35 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

CSPC Pharmaceutical Group Cash Flow

-10B-5B05B10B201720182019202020212022202320242025OperatingInvestingFinancing

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

-0.100.10.20.30.40.50.60.7Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss